A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer

✍ Scribed by Gabriel N. Hortobagyi; William Heim; Laura Hutchins; Edgardo Rivera; Bernard Mason; Daniel J. Booser; Jeffrey Kirshner

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 120 KB
• Volume: 116
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.24900